We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Upholds Diazyme Win On Assays Patents

Law360 (May 12, 2008, 12:00 AM EDT) -- An appeals court on Monday upheld a lower court's decision that Diazyme Laboratories, the life sciences division of California-based General Atomics, did not infringe Axis-Shield ASA's patents for enzymatic homocysteine tests.

Ian Gilham, Axis-Shield's CEO, said that the company's attorneys were reviewing the decision but that unless they concluded that the court's reasoning was severely flawed, they would probably not appeal it.

“The most likely outcome is that we're going to accept it and move on,” he said.

The conflict centers on the companies’ enzymatic homocysteine...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.